Cite
HARVARD Citation
Merino, M. et al. (2020). FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patients. Pediatric blood & cancer. 67 (12), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Merino, M. et al. (2020). FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patients. Pediatric blood & cancer. 67 (12), p. n/a. [Online].